Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899866/000114036120028237/nc10017928x1_8k.htm
View differences made from one to another to evaluate Alexion Pharmaceuticals, Inc.'s financial trajectory
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alexion Pharmaceuticals, Inc..
ALXN Corporate News
- Event for Officers February 2021
-
Earnings Release
Financial Exhibit February 2021 -
Earnings Release
Financial Exhibit
Regulated Disclosure January 2021 -
Financial Exhibit
New Agreement
Other Events
December 2020 -
Earnings Release
Financial Exhibit October 2020 - Event for Officers October 2020
- Event for Officers August 2020
-
Earnings Release
Financial Exhibit July 2020 -
Change in Assets
Financial Exhibit
Other Events July 2020 - New Agreement May 2020
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
SEC Filing Financial Summary
Excel Download
Loading SEC Filing Financial Summary...
Material Contracts, Statements, Certifications & more
Alexion Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Ticker: ALXN
CIK: 899866
Form Type: 8-K Corporate News
Accession Number: 0001140361-20-028237
Submitted to the SEC: Mon Dec 14 2020 9:05:44 AM EST
Accepted by the SEC: Mon Dec 14 2020
Period: Saturday, December 12, 2020
Industry: Pharmaceutical Preparations
External Resources:
Insider Transactions
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/alxn/0001140361-20-028237.htm
